CN Patent

CN104136427B — 金属酶抑制剂化合物

Assigned to Macovia Pharmaceutical Co ltd · Expires 2017-03-01 · 9y expired

What this patent protects

本发明描述了具有金属酶调节活性的化合物、以及治疗由这类金属酶介导的疾病、病症或其症状的方法。

USPTO Abstract

本发明描述了具有金属酶调节活性的化合物、以及治疗由这类金属酶介导的疾病、病症或其症状的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104136427B
Jurisdiction
CN
Classification
—
Expires
2017-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Macovia Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.